Company news

Shield Therapeutics PLC news in 2021

Shield Therapeutics PLC's news releases, calls and decks from 2021, newest first.

View company

Patient Access Expands for Accrufer®

December 16, 2021

Shield Therapeutics (STX) Life Sciences Investo...

October 7, 2021

Jose A. Menoyo Appointed as Chief Medical Officer

September 27, 2021

Investor presentation

September 21, 2021

Shield Therapeutics (STX) - Focused on US marke...

August 20, 2021

Hardman & Co Video Event | Shield Therapeut...

August 12, 2021

AEGIS-CKD study results published in AJKD

August 9, 2021

US launch of Accrufer® confirmed for July 1, 2021

June 24, 2021

Directorate Change

June 18, 2021

Results of 2021 Annual General Meeting

June 17, 2021

Appointment of new Chief Executive Officer

May 28, 2021

Shield Therapeutics (STX): Accrufer launch on s...

May 26, 2021

US update

May 21, 2021

AEGIS-H2H study results published in IBD

May 18, 2021

Commencement of trading on the OTCQX Best Market

May 17, 2021

2020 Annual Report and 2021 AGM Notice

May 13, 2021

Appointment of Two Non-Executive Directors

May 10, 2021

Preliminary Results

April 29, 2021

Study demonstrates effectiveness of ferric maltol

March 26, 2021

Shield appoints new Chief Financial Officer

March 22, 2021

Australia's TGA approves Feraccru

March 9, 2021

PDMR/PCA Transaction Notification

March 4, 2021

Publication of Circular and Notice of GM

March 1, 2021

Successful completion of £25 million Fundraise

February 26, 2021

Shield Therapeutics (STX): Beefing up for the U...

February 2, 2021

Shareholder loan facilities

January 29, 2021

Director/PDMR Shareholding

January 21, 2021

Business and trading update

January 15, 2021

Shield Therapeutics (STX): Reassessing the US o...

January 6, 2021

Calls in 2021

Decks in 2021